Funding
← Back to your selection

Key1 Capital

Activity from announced rounds

Activity in this selectionOct 18, 2026 · Jul 21, 2026

Key1 Capital is an Israeli growth-technology manager whose investment records identify Lyte, Remepy and Xsight.

Recorded funding activity

Lyte develops robotic perception systems. Remepy combines prescription medicines with therapeutic software, while Xsight designs connectivity chips for computing infrastructure. The companies pursue distinct hardware and healthcare products.

Sources
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
2
First participation on record · 1 follow-on
Funding in participating rounds
$201M
2 disclosed · full round size, not this investor’s share

By stage

Growth1
Series A1
Series C+1

By primary sector

Hardware2
Biotech1

By country

United States2
Israel1

Rounds

3 in this selection
Lyte

Lyte develops perception systems for robots and autonomous machines used in inspection, logistics and manufacturing.

$165MSeries C
Participant
Remepy

Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps

$36MSeries A
Role not disclosed
Xsight Labs

Fabless semiconductor company building connectivity chips for hyperscale, edge, and AI data centers

>$300MGrowth
Role not disclosed